Neill Moray MacKenzie
Vorstandsvorsitzender bei Trimunocor Ltd.
Ursprung des Netzwerks ersten Grades von Neill Moray MacKenzie
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
Avidex Ltd.
 Avidex Ltd. Pharmaceuticals: MajorHealth Technology Avidex Ltd. develops and discovers drugs for the treatment of cancer and autoimmune diseases. The company develops small molecule and protein therapeutics involving T cell receptors. Avidex was founded in 1999 and is headquartered in Abingdon, UK
12
| Extinct | Pharmaceuticals: Major | 12 |
Biotecnol Ltd.
 Biotecnol Ltd. BiotechnologyHealth Technology Biotecnol Ltd. engages in research & development of immuno-oncology antibody products. It specializes in recombinant antibodies, T cell engaging, multispecific antibodies and oncology. The company is headquartered in London, the United Kingdom.
2
| Private Company | Biotechnology | 2 |
Biotecnol-Serviços e Desenvolvimento SA
 Biotecnol-Serviços e Desenvolvimento SA Miscellaneous Commercial ServicesCommercial Services Biotecnol-Serviços e Desenvolvimento SA engages in the discovery, engineering, and development of multifunctional antibody molecules, directed to key therapeutic targets. The firm operates as a biopharmaceutical company working in the field of immuno-oncology. It uses Tribody technology to develop a pipeline of in-house discovered products in selected oncology indications. The company was founded in 1997 and is headquartered in Oeiras, Portugal.
1
| Private Company | Miscellaneous Commercial Services | 1 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Neill Moray MacKenzie
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
Oxxon Therapeutics, Inc.
 Oxxon Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Oxxon Therapeutics, Inc. develops and manufactures antigen-specific immunotherapies to treat patients with chronic infectious diseases and cancer. The company has three development programs in hepatitis, melanoma, and HIV. Oxxon Therapeutics was founded in 1999 by Dr. Joerg Schneider and is located at Oxford, UK. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| IMMUNOCORE HOLDINGS PLC | Biotechnology | Chairman Founder | |
Phoqus Pharmaceuticals Plc
 Phoqus Pharmaceuticals Plc Pharmaceuticals: MajorHealth Technology Phoqus Pharmaceuticals Plc develops pharmaceutical products. It's product Chronocort that helps to treat the patients with cortisol deficiency such as congenital adrenal hyperplasia and Addison's diseases. The company was founded in 1998 and is located in West Malling, UK. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer | |
Oxagen Ltd.
 Oxagen Ltd. Pharmaceuticals: MajorHealth Technology Oxagen Ltd. develops novel molecule drugs to treat inflammatory and respiratory diseases. It offers OC000459, an oral CRTH2 antagonist for the treatment of eosinophilic asthma and allergic rhino conjunctivitis. The company was founded by Nick Cross, John Irving Bellin, Mark Edwards, Trevor J. Nicholls and Ian Michael Laing on September 05 1996 and is headquartered in London, the United Kingdom. | Pharmaceuticals: Major | Founder Director/Board Member | |
| University of Oxford | College/University | Undergraduate Degree Corporate Officer/Principal | |
| ORTHOFIX MEDICAL INC. | Medical Specialties | Director/Board Member | |
| GMEC Management Co. Ltd. | Chairman | ||
| Rhodes Trust | Director/Board Member | ||
| The Ewelme Almshouse Charity | Director/Board Member | ||
| Magdalen College School Oxford Ltd | College/University | Undergraduate Degree | |
Genomics England Ltd.
 Genomics England Ltd. Miscellaneous Commercial ServicesCommercial Services Genomics England Ltd. runs and delivers 100,000 genomes project. Its flagship project sequences 100,000 genomes from NHS patients with a rare disease and their families, and patients with cancer. The company was founded by Jeremy Hunt on July 5, 2013 and is headquartered in London, the United Kingdom. | Miscellaneous Commercial Services | Director/Board Member | |
Atopix Therapeutics Ltd.
 Atopix Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Atopix Therapeutics Ltd. develops medicines to treat atopic dermatitis and severe asthma. The firm also assess the safety and pharmacokinetic profile of its back-up molecule ATX2417 in a phase I study. The company was incorporated on October 10, 2012 and is headquartered in Abingdon, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member | |
The Jenner Institute Laboratories
 The Jenner Institute Laboratories Miscellaneous Commercial ServicesCommercial Services The Jenner Institute Laboratories engages in the development of vaccine against major diseases. The company was founded in November 2005 and is headquartered in Oxford, the United Kingdom. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| Office for Strategic Co-ordination of Health Research | Chairman | ||
| University of Alberta | College/University | Undergraduate Degree | |
| SENSYNE HEALTH PLC | Miscellaneous Commercial Services | Chairman | |
The Oxford Health Alliance
 The Oxford Health Alliance Miscellaneous Commercial ServicesCommercial Services The Oxford Health Alliance is a British charitable company that focuses on preventing chronic diseases. The non-profit company is based in Greater London, UK. | Miscellaneous Commercial Services | Chairman | |
| The Wellcome Trust Centre for Human Genetics | Founder | ||
| The Gray Laboratory Cancer Research Trust | Director/Board Member | ||
| Oxford University Hospitals NHS Trust | Investment Trusts/Mutual Funds | Director/Board Member | |
Biospring Management Partners LP
 Biospring Management Partners LP Investment ManagersFinance Biospring Management Partners LP (Biospring Partners) is a venture capital firm founded in 2020 by Michelle Dipp and Jennifer Lumba. The firm is headquartered in New York. | Investment Managers | Consultant / Advisor | |
| Oxford Centre for Diabetes Endocrinology & Metabolism | Corporate Officer/Principal | ||
F. Hoffmann-La Roche Ltd.
 F. Hoffmann-La Roche Ltd. Pharmaceuticals: MajorHealth Technology F. Hoffmann-La Roche Ltd. manufactures pharmaceutical products. It offers pharmaceutical drugs, pharmaceutical instruments, and diagnostics solutions. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland. | Pharmaceuticals: Major | Director/Board Member | |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Director/Board Member | |
Academy of Medical Sciences
 Academy of Medical Sciences Miscellaneous Commercial ServicesCommercial Services The Academy of Medical Sciences was founded in 1998 and provides biomedical and health research services. The non-profit company is based in London, UK. | Miscellaneous Commercial Services | President | |
| ROCHE HOLDING AG | Pharmaceuticals: Major | Director/Board Member | |
Wellcome Plc
 Wellcome Plc Miscellaneous Commercial ServicesCommercial Services Part of GSK Plc, Wellcome Plc is a British company that specializes in the discovery, development, manufacture, and sale of human healthcare products. The company is based in Greenford, UK. | Miscellaneous Commercial Services | Director/Board Member | |
| POSTNL N.V. | Air Freight/Couriers | Director/Board Member | |
Powderject Pharmaceuticals Plc
 Powderject Pharmaceuticals Plc Medical SpecialtiesHealth Technology Powderject Pharmaceuticals Plc develops pharmaceutical products. It offers researching, developing, manufacturing and marketing for existing and next generation vaccines. The company was founded in 1993 and is located in Oxford, UK | Medical Specialties | Founder | |
Our Future Health Uk
 Our Future Health Uk Miscellaneous Commercial ServicesCommercial Services Our Future Health UK is a collaboration between the public, private, and charity sectors. Our Future Health UK is a member of the UK Health Data Research Alliance, which establishes best practices for the ethical use of UK health data for research at scale. The private company is based in Manchester, UK. The British company aims to be the largest health research program in the UK, bringing people together to develop new ways to prevent, detect, and treat diseases. The company is committed to protecting participants' confidentiality while maximizing the opportunity to help researchers tackle serious diseases. The CEO of the company is Andrew Roddam. | Miscellaneous Commercial Services | Director/Board Member | |
Oxford Science Enterprises PLC
 Oxford Science Enterprises PLC Investment ManagersFinance Oxford Science Enterprises PLC (Oxford Science Enterprises) is a venture capital firm founded in 2015. The firm is headquartered in Oxford, United Kingdom. | Investment Managers | Director/Board Member | |
| Portuguese Catholic University | College/University | Corporate Officer/Principal | |
Associação Nacional de Jovens Empresários
 Associação Nacional de Jovens Empresários Miscellaneous Commercial ServicesCommercial Services Associação Nacional de Jovens Empresários provides enterprise development and business training for charity. It offers monitoring, advising, and mentoring. The company was founded in July 29, 1986 and is headquartered in Porto, Portugal. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| Vida Rhein SA | Director/Board Member | ||
| Associação Portuguesa de Bioindústrias | Founder | ||
| King's College London | College/University | Doctorate Degree | |
Adaptimmune LLC
 Adaptimmune LLC Medical/Nursing ServicesHealth Services Part of Adaptimmune Therapeutics Plc, Adaptimmune LLC is a company that focuses on the use of T cell therapy to treat cancer and infectious disease. The company is based in Philadelphia, PA. | Medical/Nursing Services | President | |
| TRILLIUM THERAPEUTICS | Biotechnology | Director/Board Member | |
| University of Bristol | College/University | Doctorate Degree | |
| ADAPTIMMUNE THERAPEUTICS PLC | Biotechnology | Founder | |
MediGene, Inc.
 MediGene, Inc. Pharmaceuticals: MajorHealth Technology MediGene, Inc. develops herpes simplex virus technologies for the treatment of tumors and for gene delivery. The company was founded by Ram Bhatt and Frank Tufaro and is headquartered in San Diego, CA. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| London Business School | College/University | Masters Business Admin | |
Adaptimmune Ltd.
 Adaptimmune Ltd. Medical/Nursing ServicesHealth Services Adaptimmune Ltd. develops T cell therapies to treat cancer, human immunodeficiency virus, and infectious diseases. It utilizes the T cell to target and destroy cancerous and infected cells by using affinity T cell receptor proteins as a means of strengthening patient T cell responses. The company was founded by Bent K. Jakobsen, James Julian Noble and Helena Katrina Tayton-Martin in 2008 and is headquartered in Oxford, the United Kingdom. | Medical/Nursing Services | Founder | |
Heptares Therapeutics Ltd.
 Heptares Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Heptares Therapeutics Ltd. designs and develops new medicines targeting G protein-coupled receptors. It builts an exciting discovery and development pipeline of novel drug candidates, which have the potential to transform the treatment of serious diseases, including alzheimer's disease, parkinson's disease, schizophrenia, migraine and diabetes. The company was founded by Richard Henderson, Fiona Hamilton Marshall, Ludwig Michael Steinmetz, Christopher G. Tate and Malcolm Weir in 2007 and is headquartered in Welwyn Garden City, the United Kingdom. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| University of Leeds | College/University | Doctorate Degree | |
Microbiotica Ltd.
 Microbiotica Ltd. BiotechnologyHealth Technology Microbiotica Ltd. performs research and experimental development on biotechnology. The company was founded by Michael Anthony Romanos, Trevor David Lawley and Gordon Dougan in December 2016 and is headquartered in Cambridge, the United Kingdom. | Biotechnology | Director/Board Member | |
| PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal |
Statistik
International
| Vereinigtes Königreich | 33 |
| Vereinigte Staaten | 8 |
| Portugal | 5 |
| Kanada | 3 |
| Schweiz | 3 |
Sektoral
| Health Technology | 19 |
| Consumer Services | 9 |
| Commercial Services | 9 |
| Finance | 3 |
| Transportation | 3 |
Operativ
| Director/Board Member | 75 |
| Chairman | 24 |
| Corporate Officer/Principal | 19 |
| Chief Executive Officer | 12 |
| Founder | 11 |
Am stärksten vernetzte Beziehungen
- Börse
- Insiders
- Neill Moray MacKenzie
- Unternehmensverbindungen
